{"id":"W2091264926","doi":"10.1111/j.1365-2141.2010.08387.x","title":"Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia","year":2010,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Clofarabine; Medicine; Cytarabine; Internal medicine; Refractory (planetary science); Nucleoside analogue; Fludarabine; Oncology; Regimen; Gastroenterology; Chemotherapy; Nucleoside; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001981666,0.0008480521,0.001149522,0.0004012494,0.0002958727,0.0005368415,0.0005367185,0.0006735952,0.003387044],"category_scores_gemma":[0.000782483,0.0003774108,0.0007307123,0.0004170662,0.00073677,0.0003906651,0.0004019112,0.001268235,0.0007839242],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000887457,"about_ca_system_score_gemma":0.001946941,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002555154,"about_ca_topic_score_gemma":0.008314108,"domain_scores_codex":[0.9993985,0.0004039041,0.00003001499,0.00004376803,0.00004928449,0.0000745089],"domain_scores_gemma":[0.9993536,0.00008082096,0.000113954,0.00003429608,0.00002437375,0.0003928242],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7689449,0.03020079,0.02431834,0.001142945,0.001843589,0.001047937,0.0006358161,0.003518671,0.04227719,0.0006947833,0.008688169,0.116687],"study_design_scores_gemma":[0.5882852,0.3536269,0.0437236,0.00009418321,0.0005439598,0.0009305883,0.0001376637,0.001520227,0.002245879,0.0002615346,0.008592933,0.00003726409],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950594,0.001330483,0.0001416347,0.0003176391,0.00003916849,0.001149457,0.0006548303,0.00003646507,0.001271009],"genre_scores_gemma":[0.9868441,0.001712501,0.001746728,0.001083612,0.00009333534,0.001595969,0.003584844,0.00001961154,0.003319314],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003387044,"threshold_uncertainty_score":0.01133078,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02900181210569678,"score_gpt":0.3794796022563477,"score_spread":0.3504777901506509,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}